BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 707463)

  • 1. Pancreatic excretion test and barrier hypothesis in progression of chronic pancreatitis.
    Noda A; Hayakawa T; Horiguchi Y; Naruse S; Iinuma Y
    Am J Gastroenterol; 1978 Jun; 69(6):673-82. PubMed ID: 707463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic excretion of 5,5-dimethyl-2,4-oxazolidinedione in patients with chronic pancreatitis.
    Noda A; Hayakawa T; Aoki I; Horiguchi Y; Toda Y
    Am J Dig Dis; 1975 Nov; 20(11):1019-26. PubMed ID: 1199992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between pancreatic exocrine function and histological changes in chronic pancreatitis.
    Hayakawa T; Kondo T; Shibata T; Noda A; Suzuki T; Nakano S
    Am J Gastroenterol; 1992 Sep; 87(9):1170-4. PubMed ID: 1519575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin-stimulated peak lipase concentration in duodenal drainage fluid: a new pancreatic function test.
    Conwell DL; Zuccaro G; Morrow JB; Van Lente F; Obuchowski N; Vargo JJ; Dumot JA; Trolli P; Shay SS
    Am J Gastroenterol; 2002 Jun; 97(6):1392-7. PubMed ID: 12094856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of pancreatic excretion test with dimethadione and oral BT-PABA test in chronic pancreatitis.
    Noda A; Hayakawa T; Kondo T; Katada N; Kameya A
    Dig Dis Sci; 1983 Mar; 28(3):230-5. PubMed ID: 6600678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Excretory pancreatic function: comparison of indirect function tests with the secretin-cholecystokinin test].
    Wildgrube HJ; Schröter R; Classen M
    Dtsch Med Wochenschr; 1982 Nov; 107(46):1751-5. PubMed ID: 7140556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic excretion of 5, 5-dimethyl-2, 4-oxazolidinedione in normal subjects.
    Noda A; Hayakawa T; Nakajima S; Suzuki T; Toda Y
    Am J Dig Dis; 1975 Nov; 20(11):1011-8. PubMed ID: 1199991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatolithiasis and pancreatic carcinoma. Evaluation of pancreatic excretion test with 5,5-dimethyl-2,4-oxazolidinedione.
    Noda A; Kamiya N; Takayama T; Hayakawa T
    Arch Intern Med; 1977 Jun; 137(6):754-60. PubMed ID: 869646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of accuracy of plasma alpha-amino nitrogen profiles as an indicator of exocrine pancreatic function both after continuous and bolus stimulation of the pancreas with secretin and cholecystokinin-pancreozymin.
    Lembcke B; Konle O; Duan LP; Caspary WF
    Z Gastroenterol; 1994 Dec; 32(12):679-83. PubMed ID: 7871858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of pancreatic function. Determination of fecal chymotrypsin and the secretin-pancreozymin test. Comparative study].
    Tympner F; Reiner T; Domschke W
    Fortschr Med; 1977 Jul; 95(27):1711-4. PubMed ID: 903053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Excretory pancreas function. Secretion of protein, calcium and citrate in probands with a normal pancreas and in patients with chronic pancreatitis].
    Weber H; Dummler W; Liebe S
    Z Gastroenterol; 1993 Oct; 31(10):592-9. PubMed ID: 8256473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlative study of histopathological findings and pancreozymin-secretin test in pancreas disease (author's transl)].
    Sakumoto K; Sakurai S
    Rinsho Byori; 1976 Jul; 24(7):519-21. PubMed ID: 987339
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on duodenal cyclic AMP content content in pancreatic disease after administration of pancreozymin and secretin.
    Matsumoto R; Arima T; Tsunashima T; Kawai K; Suwaki K; Tanigawa T; Kita S; Nagashima H
    Am J Gastroenterol; 1980 Aug; 74(2):138-42. PubMed ID: 6255794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between bolus injection and infusion of secretin and pancreozymin in the diagnosis of chronic pancreatic disease (one hour test).
    Farini R; Del Favero G; Adorati M; Pedrazzoli S; Fabris G; Giordano P; D'Angelo A; Zotti E; Lise M; Chiaramonte M; Salvagnini M; Naccarato R
    Acta Hepatogastroenterol (Stuttg); 1977 Dec; 24(6):462-8. PubMed ID: 602625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pancreatitis and papillary stenosis: endoscopic retrograde pancreatography (ERP) vs. exocrine functional tests (author's transl)].
    Löffler A; Miederer SE; Glänzer K
    Leber Magen Darm; 1976 Aug; 6(4):235-46. PubMed ID: 1028876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The secretin-pancreozymin test in the diagnosis of pancreatic insufficiency].
    Rick W
    Internist (Berl); 1970 Mar; 11(3):110-7. PubMed ID: 4928886
    [No Abstract]   [Full Text] [Related]  

  • 17. [Does the secretin/pancreozymin test require a correction for volume loss?].
    Hauzeur F
    Dtsch Z Verdau Stoffwechselkr; 1987; 47(4):178-81. PubMed ID: 3436281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal pancreatic exocrine function does not exclude MRI/MRCP chronic pancreatitis findings.
    Alkaade S; Cem Balci N; Momtahen AJ; Burton F
    J Clin Gastroenterol; 2008 Sep; 42(8):950-5. PubMed ID: 18645530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The secretin-pancreozymin test in the diagnosis of exocrine pancreatic function (author's transl)].
    Pointner H
    Wien Klin Wochenschr; 1973 Oct; 85(40):665-7. PubMed ID: 4747003
    [No Abstract]   [Full Text] [Related]  

  • 20. Exocrine pancreatic function assessed by secretin cholangio-Wirsung magnetic resonance imaging.
    Calculli L; Pezzilli R; Fiscaletti M; Casadei R; Brindisi C; Gavelli G
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):192-5. PubMed ID: 18397857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.